A61P 7 - Drugs for disorders of the blood or the extracellular fluid

Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/2004
12/22/2004	EP1487541A2 Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases
12/22/2004	EP1487540A2 Storage stable eplerenone formulation
12/22/2004	EP1487494A2 Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
12/22/2004	EP1487472A2 Stabilization of hypoxia inducible factor (hif) alpha
12/22/2004	EP1487471A2 Methods for treating autoimmune disorders and reagents related thereto
12/22/2004	EP1453949A4 Production of cell suspensions
12/22/2004	EP1311284B1 Saratin for inhibiting platelet adhesion to collagen
12/22/2004	EP1133486B1 Nonsteroidal antiinflammatories
12/22/2004	EP0809437B1 Thiols to promote hematopoietic progenitor cell growth
12/22/2004	CN1556811A 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/22/2004	CN1556710A Pharmaceutical composition comprising factor VII polypeptides and factor XI polypeptides
12/22/2004	CN1555842A Chinese medicine for expelling stasis
12/22/2004	CN1555834A Medicinal composition containing salvia root effective component and ligusticum effecive component and its preparation
12/22/2004	CN1555806A Paeonoside injection and its preparation method and use
12/22/2004	CN1555803A Application of ferulaic acid chuanxiong rhizome qin in preparing medicine
12/22/2004	CN1181099C Anticoagulation and thrombolytic thrombus target fusion mA5UKB
12/22/2004	CN1181097C Monochain antibody with dual specificities possessing activity for restraining adherence and aggregation of blood platelets
12/22/2004	CN1181094C Hemopoiesis factor and its application
12/22/2004	CN1181091C Factor Xa inhibitors
12/22/2004	CN1180823C Oral liquid for treating female nutritional anemia and its preparing process
12/22/2004	CN1180821C Medicine for treating cerebral thrombus and its prepn process
12/22/2004	CN1180792C Chinese medicine preparation for preventing and treating leucocytopenia and its preparation method
12/22/2004	CN1180786C High-efficiency fast styptic
12/21/2004	US6833443 Gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine
12/21/2004	US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases
12/21/2004	US6833379 As diuretic agent
12/21/2004	US6833364 Inhibiting degradation of cyclic guanosine monophosphate; cardiovascular disorders; such as 3-(4-amino-5-cyclopropyl-pyrimidin-2-yl)-1-(2-fluorobenzyl)1H-pyrazolo-(3,4 -b)-pyridine
12/21/2004	US6833363 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
12/21/2004	US6833243 For diagnosis of psychosis/schizophrenia via detection of mutant allele
12/21/2004	CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/16/2004	WO2004108928A1 Cholesterol biosynthesis pathway modulators and uses thereof
12/16/2004	WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell
12/16/2004	WO2004108729A1 [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF
12/16/2004	WO2004108718A1 Aroyl semicarbazide derivatives against thromboembolic diseases
12/16/2004	WO2004108683A1 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators
12/16/2004	WO2004108132A1 Staurosporine derivatives for hypereosinophilic syndrome
12/16/2004	WO2004108121A1 Use of hif alpha stabilizers for enhancing erythropoiesis
12/16/2004	WO2004010951A3 Method of treating tumors
12/16/2004	WO2003090514A8 Adipocyte complement related protein zacrp14
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254249 Nonsteroidal antiinflammatory agents
12/16/2004	US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004	US20040254224 Medicaments
12/16/2004	US20040254223 Process for the preparation of amorphous form of torsemide
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254189 Jnk inhibitors
12/16/2004	US20040254176 Hypotensive agents; cardiovascular disorders; antidiabetic agents; skin disorders;kidney disorders; headaches; vision defects; strokes; synergistic mixture of amlodipine, benazepril and hydrochlorothiazide; oral administering
12/16/2004	US20040254175 Antitumor agenst; thrombosis; arteriosclerosis; cardiovascular disorders; antiinflammatory agents
12/16/2004	US20040254166 Substituted phenyl acetamides and their use as protease inhibitors
12/16/2004	US20040254145 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
12/16/2004	US20040254116 Contactor tissue with transforming growth factor kinase receptors; modulate cell proliferation
12/16/2004	US20040254106 Modified factor ix
12/16/2004	US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents
12/16/2004	US20040253686 Novel human kunitz-type inhibitors and methods relating thereto
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253276 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
12/16/2004	US20040253275 Pharmaceutical and cosmetic carrier or composition for topical application
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	CA2528233A1 Aroylsemicarbazide derivatives against thromboembolic diseases
12/16/2004	CA2528156A1 Staurosporine derivatives for hypereosinophilic syndrome
12/16/2004	CA2526496A1 Use of hif alpha stabilizers for enhancing erythropoiesis
12/15/2004	EP1486491A1 Carboxyoic acid compounds and drugs containing the compounds as the active ingredient
12/15/2004	EP1486487A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate
12/15/2004	EP1486485A1 Novel crystals of 5-hydroxycarbamimidoyl-2-hydroxybenzenesulfonamide derivative
12/15/2004	EP1485476A2 Dimeric tf antagonist
12/15/2004	EP1485391A2 Phosphate transport inhibitors
12/15/2004	EP1485381A1 Azolylaminoazine as inhibitors of protein kinases
12/15/2004	EP1485380A1 Azolylaminoazines as inhibitors of protein kinases
12/15/2004	EP1485371A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
12/15/2004	EP1485360A2 Sodium channel blockers
12/15/2004	EP1485359A2 Sodium channel blockers
12/15/2004	EP1485132A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
12/15/2004	EP1485121A2 Activated protein c formulations
12/15/2004	EP1485104A1 Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative
12/15/2004	EP1485100A1 Azinylaminoazoles as inhibitors of protein kinases
12/15/2004	EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
12/15/2004	EP1485094A1 FORM OF PRESENTATION FOR 3- (2-{ 4-(HEXYLOXYCARBONYLAMINO-IMINO-METHYL)-PHENYLAMINO -METHYL}-1-METHYL-1iH /i -BENZIMIDAZOL-5-CARBONYL)-PYRIDIN-2-YL-AMINO PROPIONIC ACID ETHYL ESTER TO BE ADMINISTERED ORALLY
12/15/2004	EP1485092A1 Use of rapamycin for inhibiting of cell death
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
12/15/2004	EP1485083A2 Dexanabinol and dexanabinol analogs regulate inflammation related genes
12/15/2004	EP1425015A4 Tetrahydroquinoline derivatives as antithrombotic agents
12/15/2004	EP1401862A4 Peptide compounds for counteracting reactive oxygen species and free radicals
12/15/2004	EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists
12/15/2004	EP1309594B1 Benzimidazole derivatives, preparation and therapeutic use thereof
12/15/2004	EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/15/2004	EP1226160B1 Novel antiarrhythmic peptides
12/15/2004	EP1226137B8 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity
12/15/2004	EP1226122B1 Bicyclic vasopressin agonists
12/15/2004	EP1028752B1 Platelet substitutes and conjugation methods suitable for their preparation
12/15/2004	EP1015022B1 New improved formulation for treatment of thromboembolism
12/15/2004	EP0863755B1 Antithrombotic diamines
12/15/2004	EP0638088B1 Hybrid human/porcine factor viii
12/15/2004	CN1555379A Spirocyclic-6,7-dihydro-5h-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines
12/15/2004	CN1555376A 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity
12/15/2004	CN1555375A Compounds for inhibiting the release of inflammatory cytokines
12/15/2004	CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives

1 ... 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 ... 671